| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: E9AWX6
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.465 |
| CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.445 |
| CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.326 |
| DOC_MAPK_gen_1 | 52 | 61 | PF00069 | 0.524 |
| DOC_MAPK_MEF2A_6 | 54 | 63 | PF00069 | 0.491 |
| LIG_14-3-3_CanoR_1 | 15 | 21 | PF00244 | 0.645 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.623 |
| LIG_FHA_1 | 56 | 62 | PF00498 | 0.475 |
| LIG_FHA_2 | 26 | 32 | PF00498 | 0.538 |
| LIG_LIR_Apic_2 | 40 | 46 | PF02991 | 0.598 |
| LIG_LIR_Gen_1 | 58 | 66 | PF02991 | 0.349 |
| LIG_LIR_Gen_1 | 68 | 79 | PF02991 | 0.354 |
| LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.327 |
| LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.299 |
| LIG_PDZ_Class_2 | 80 | 85 | PF00595 | 0.348 |
| LIG_Pex14_2 | 74 | 78 | PF04695 | 0.448 |
| LIG_REV1ctd_RIR_1 | 80 | 85 | PF16727 | 0.365 |
| LIG_SH2_NCK_1 | 43 | 47 | PF00017 | 0.626 |
| LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.630 |
| LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.587 |
| LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.385 |
| LIG_SH2_STAT5 | 81 | 84 | PF00017 | 0.355 |
| LIG_SH3_3 | 31 | 37 | PF00018 | 0.664 |
| LIG_SH3_3 | 69 | 75 | PF00018 | 0.345 |
| LIG_TRFH_1 | 71 | 75 | PF08558 | 0.401 |
| MOD_CK1_1 | 19 | 25 | PF00069 | 0.659 |
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.644 |
| MOD_GSK3_1 | 4 | 11 | PF00069 | 0.564 |
| MOD_NEK2_1 | 55 | 60 | PF00069 | 0.564 |
| MOD_Plk_4 | 37 | 43 | PF00069 | 0.583 |
| MOD_Plk_4 | 44 | 50 | PF00069 | 0.564 |
| MOD_Plk_4 | 55 | 61 | PF00069 | 0.428 |
| MOD_Plk_4 | 8 | 14 | PF00069 | 0.618 |
| TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.391 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PCA5 | Leptomonas seymouri | 80% | 93% |
| A0A0S4J5H3 | Bodo saltans | 57% | 69% |
| A0A3S7WYH2 | Leishmania donovani | 90% | 100% |
| A4HDK9 | Leishmania braziliensis | 78% | 100% |
| A4I0X2 | Leishmania infantum | 90% | 100% |
| C9ZWH5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 97% |
| Q4QAJ8 | Leishmania major | 88% | 100% |
| V5BB00 | Trypanosoma cruzi | 58% | 97% |